FIELD: medicine, hepatology.
SUBSTANCE: invention relates to methods for treatment of patients suffering with liver diseases. Method involves administration of L-ornithine-L-aspartate by every day intravenous drop route for 7-10 days. Preliminary 10 g of this preparation are dissolved in 400 ml of low-molecular dextran. This method provides the effective treatment based on improved hemodynamics in liver.
EFFECT: improved method of treatment.
5 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF LIVER DISEASES | 2006 |
|
RU2334499C2 |
METHOD FOR PREDICTING COMPLICATIONS OCCURRENCE RISK CAUSED BY PLASMAPHERESIS ACTION UPON CHRONIC HEPATIC DISEASE PATIENTS | 2006 |
|
RU2321337C1 |
METHOD AND DEVICE FOR HEPATIC HEMODYNAMICS ESTIMATION | 2007 |
|
RU2372022C2 |
METHOD OF ESTIMATING LIVER FIBROSIS | 2010 |
|
RU2453268C2 |
METHOD FOR TREATMENT OF HEPATIC DISEASE | 2001 |
|
RU2219930C2 |
METHOD FOR SELECTING PHARMACOLOGICAL PREPARATION FOR TREATING HEPATIC ENCEPHALOPATHY | 2003 |
|
RU2241224C1 |
METHOD FOR TREATING HEPATIC DISEASES | 2000 |
|
RU2180227C1 |
METHOD FOR DETERMINING DIASTOLIC DYSFUNCTION OF THE RIGHT VENTRICLE | 2018 |
|
RU2696076C1 |
METHOD FOR APPLYING PHYSIOTHERAPEUTIC LIVER TREATMENT | 2002 |
|
RU2232609C2 |
METHOD FOR PREVENTING LIVER DAMAGE IN ACUTE PANCREATITIS | 2023 |
|
RU2815160C1 |
Authors
Dates
2006-11-10—Published
2004-07-19—Filed